See also this year's filing and all EDGAR filings for this company.
PDF Report 0001785530_2023_Werewolf_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001785530, Werewolf Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 140,200,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 8,988,000 |
| 3 | remainder_Assets | 11,057,000 |
| 4 | LiabilitiesCurrent | 23,989,000 |
| 5 | LiabilitiesNoncurrent | 13,919,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 18,696,000 |
| 9 | ResearchAndDevelopmentExpense | 53,761,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 18,647,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 160,245,000 |
| 1 | Liabilities | 37,908,000 |
| 2 | Expenses | 72,457,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 122,337,000 |
| 5 | NetIncome | -53,810,000 |
| 6 | ComprehensiveNetIncome | -53,810,000 |
| 7 | BaseVar | 144,628,500 |
| 8 | EconomicCapitalRatio | 1.58 |